Dr. Johnathan Lancaster describes advances in the field of testing for hereditary endometrial and colon cancers, which are some of the most common cancers and are significant public health problems.

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.